Close Menu

When Faster IS Better

A WSJ op-ed piece by Richard Miller, an oncologist and the CEO of the Bay Area-based Pharmacyclics, argues that the FDA needs to get cancer drugs to market quicker. Maybe he should direct his eye toward Scottish scientists at the universities of Glasgow and Strathclyde, who are developing a large molecular sensing device they plan to use to test for signature patterns of drug side effects.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.